Autologous MSC-NTF Cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Autologous MSC-NTF Cells, covering 2024-06-06 to 2024-06-06. Get the full timeline:
Most recent: Clinical Trial Update: Phase 2, Randomized, Double Blind, Placebo Controlled Multicenter Study of Autologous MSC-NTF Cells in Patients With ALS [Phase 2]